Literature DB >> 20947865

Elevated oxidative stress markers and its relationship with endothelial dysfunction in Behçet disease.

Nusret Acikgoz1, Necip Ermiş, Jülide Yağmur, Mehmet Cansel, Yelda Karincaoğlu, Halil Ataş, Bilal Cuglan, Irfan Barutcu, Hasan Pekdemir, Ramazan Özdemir.   

Abstract

Behçet's disease (BD) is a multisystemic disorder characterized by endothelial dysfunction. However, the relationship between oxidative stress and endothelial function has not been clearly shown. We investigated the relationship between oxidative stress markers and endothelial function in patients with BD. Patients with BD (n = 40) having active disease and sex- and age-matched 40 controls were included. Endothelial function was assessed by flow-mediated dilatation (FMD) technique. Serum gamma-glutamyltransferase (GGT) and high-sensitive C-reactive protein levels (hsCRP) were measured in all participants. Brachial artery FMD was significantly lower in patients with BD than in controls. Gamma-glutamyltransferase and hsCRP levels were higher in patients with BD than in controls. Also, GGT and hsCRP levels were inversely correlated with endothelial function. Oxidative stress markers are elevated in patients with BD having active disease. This may be one of the reasons behind the vasculitis in active BD.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20947865     DOI: 10.1177/0003319710382417

Source DB:  PubMed          Journal:  Angiology        ISSN: 0003-3197            Impact factor:   3.619


  5 in total

1.  Association of Rho-kinase 1 (ROCK1) gene polymorphisms with Behçet's disease.

Authors:  Elif Oguz; Abdullah Tuncay Demiryürek; Yavuz Pehlivan; Bünyamin Kisacik; Esma Ozkara; Serdar Oztuzcu; Belgin Alasehirli; Ahmet Mesut Onat
Journal:  Mol Diagn Ther       Date:  2014-08       Impact factor: 4.074

2.  Neutrophil/lymphocyte ratio and platelet/lymphocyte ratio in Behçet's disease: which and when to use?

Authors:  Marwa Hammad; Omaima Zakaria Shehata; Shaimaa Mohamed Abdel-Latif; Amany Mohamed Mohiey El-Din
Journal:  Clin Rheumatol       Date:  2018-07-07       Impact factor: 2.980

3.  Levels of F2 isoprostane in Behcet's disease: Correlation with cardiometabolic risk factors.

Authors:  Gul Sagun; Aytekin Oguz; Banu Mesci; Banu Isbilen; Mukaddes Kavala; Havva Keskin; Mumtaz Takir; Sibel Zehra Aydin
Journal:  Redox Rep       Date:  2015-04-13       Impact factor: 4.412

4.  An investigation of thiol/disulfide homeostasis in patients with Behçet's disease.

Authors:  Sevinc Can Sandikci; Seda Colak; Ahmet Omma; Mehmet E Enecik; Zeynep Ozbalkan; Salim Neselioglu; Ozcan Erel
Journal:  Arch Med Sci       Date:  2019-07-18       Impact factor: 3.318

5.  Endocan Measurement for Active Behçet Disease.

Authors:  Ayhan Kul; Orhan Ateş; Meltem Alkan Melikoğlu; Mahir Uğur; Nurinnisa Öztürk; Gülsüm Erkayhan; İbrahim Koçer
Journal:  Arch Rheumatol       Date:  2017-03-24       Impact factor: 1.472

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.